Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysisMykhailo Buchynskyi, Oleksandr Kamyshnyi, Iryna Kamyshna et al.|Frontiers in Immunology|2023Cited by 37
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian ExperienceOleksandr Kamyshnyi, Olena Moshynets, G. D. Koval et al.|International Journal of Molecular Sciences|2023Cited by 25
Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver diseaseMykhailo Buchynskyi, Oleksandr Kamyshnyi, Pavlo Petakh et al.|Frontiers in Microbiology|2025Cited by 22
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current EvidenceMykhailo Buchynskyi, Oleksandr Kamyshnyi, Iryna Kamyshna et al.|Viruses|2023Cited by 20
Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort studyMykhailo Buchynskyi, Oleksandr Kamyshnyi, Pavlo Petakh et al.|Frontiers in Genetics|2024Cited by 15